Publications by authors named "Poorva Vaidya"

Claim this Profile
M
Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell Carcinoma.
Poorva Vaidya, Sharon Wu, Dave Bryant, Curtis J Perry, Varsha Prakash

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence.
Poorva Vaidya, Ezra E W Cohen

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine.
Poorva Vaidya, Huan-You Wang, Michelle D Don, Brian R Hinds, James K Mangan

Leuk Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
Gino K In, Poorva Vaidya, Alexandra Filkins, David J Hermel, Kevin G King

J Cancer Res Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantified Kinematics to Evaluate Patient Chemotherapy Risks in Clinic.
Zaki Hasnain, Tanachat Nilanon, Ming Li, Aaron Mejia, Anand Kolatkar, Poorva Vaidya

JCO Clin Cancer Inform· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors.
Ashley Hagiya, Poorva Vaidya, Tarek Khedro, Bassam Yaghmour, Imran Siddiqi

World J Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin-Related Interstitial Lung Injury in FLT3 Acute Myeloid Leukemia Post-Allogeneic Transplant.
Poorva Vaidya, Tarek Khedro, Bassam Yaghmour, George Yaghmour

World J Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent radiation therapy with programmed cell death protein 1 inhibition leads to a complete response in advanced cutaneous squamous cell carcinoma.
Poorva Vaidya, Arjun Mehta, Omar Ragab, Sonia Lin, Gino K In

JAAD Case Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-32 is a molecular marker of a host defense network in human tuberculosis.
Dennis Montoya, Megan S Inkeles, Phillip T Liu, Susan Realegeno, Rosane M B Teles, Poorva Vaidya

Sci Transl Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis